Cover Image
Market Research Report

North America Glucose Monitoring Market Forecast 2019-2027

Published by Inkwood Research Product code 429443
Published Content info 133 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Glucose Monitoring Market Forecast 2019-2027
Published: June 10, 2019 Content info: 133 Pages
Description

KEY FINDINGS

The North America glucose monitoring system market accounted for the highest revenue share of the global market in 2018. Over the predicted years of 2019-2027, the CGMS market is expected to witness a CAGR of 31.03%, generating total revenue of $XX million. Meanwhile, the SMBG market is expected to grow at 4.69% CAGR while generating a total revenue of $XX million, by the end of the said forecast period.

MARKET INSIGHTS

Prevalence rates of diabetes in North America are in the range of XX% to XX% that is close to the top of the global scale. The U.S is the largest national diabetes market and Canada's share in the global market is far greater than its population. Governments are strategizing several initiatives for the prevention of diabetes in the country and creating awareness among people with regular diabetes screenings, lifestyle counselling, and diabetes education, with no out of pocket costs. The diabetic products are also provided online and that too at discounted rates. The administrations are also making sure that all the individuals, especially in Canada, are covered for medically necessary physician and hospital series.

COMPETITIVE INSIGHTS

Becton Dickinson And Company, Roche Diagnostics, ARKRAY Inc., Johnson and Johnson, Wockhardt, Senseonics Inc., Terumo, I-Sens Inc., Abbott, Apex Biotechnology Corp., Dexcom, GlySens Inc., Nemaura Medical Inc., B Braun Melsungen AG, Insulet Corp., Morepen Laboratories Ltd., Medtronic, Ypsomed, Ascensia, and Tandem Diabetes Care are some of the leading companies in this region.

Table of Contents
Product Code: 2949

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE STUDY MARKET
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
  • 2.2. BOTTOM-UP APPROACH
  • 2.3. TOP-DOWN APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CGMS MARKET IS ANTICIPATED TO BE A FASTEST GROWING MARKET
    • 3.2.2. SELF-MONITORING OF BLOOD GLUCOSE HAS HUGE MARKET OPPORTUNITY
    • 3.2.3. COLLABORATION OF SIGNIFICANT COMPANIES TO DEVELOP INTEGRATED CGMS-ENABLED INSULIN PUMPS

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN THE INCIDENCE OF DIABETES
    • 4.2.2. INCREASED FOCUS ON RESEARCH AND DEVELOPMENT
    • 4.2.3. TECHNOLOGY INTEGRATION
    • 4.2.4. INCREASED AFFORDABILITY OF CGMS AND SMBG
    • 4.2.5. TECHNOLOGICAL ADVANCES IN GMS DEVICES
    • 4.2.6. AWARENESS AMONG THE GENERAL POPULATION
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HINDERANCE FROM GOVERNMENT REGULATIONS
    • 4.3.2. INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
    • 4.3.3. LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. RISING EMERGING TECHNOLOGIES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. INTENSE COMPETITION AMONG VENDORS
    • 4.5.2. INACCURACY IN READING OF GMS DEVICES
    • 4.5.3. INCREASINGLY STRINGENT GOVERNMENT REGULATIONS

5. CGMS MARKET BY COMPONENT TYPE

  • 5.1. SENSORS
  • 5.2. TRANSMITTERS AND RECEIVERS
  • 5.3. INSULIN PUMP

6. CGMS MARKET BY END-USERS

  • 6.1. HOME SETTINGS
  • 6.2. DIAGNOSTICS AND CLINICS
  • 6.3. HOSPITALS

7. CGMS MARKET BY DEMOGRAPHICS

  • 7.1. ADULT POPULATION (>14YEARS)
  • 7.2. CHILD POPULATION (≤14YEARS)

8. SMBG MARKET OVERVIEW

9. SMBG MARKET BY COMPONENT TYPE

  • 9.1. TEST STRIPS
  • 9.2. GLUCOSE METER
  • 9.3. LANCETS

10. SMBG MARKET BY END-USER

  • 10.1. HOME SETTINGS
  • 10.2. CLINICAL
  • 10.3. HOSPITAL

11. SMBG MARKET BY APPLICATION

  • 11.1. TYPE 1 DIABETES
  • 11.2. TYPE 2 DIABETES
  • 11.3. GESTATIONAL DIABETES

12. KEY ANALYTICS

  • 12.1. PORTER'S 5 FORCE ANALYSIS
    • 12.1.1. THREAT OF NEW ENTRANT
    • 12.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 12.1.3. BARGAINING POWER OF BUYERS
    • 12.1.4. BARGAINING POWER OF SUPPLIER
    • 12.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 12.2. KEY BUYING CRITERIA
  • 12.3. KEY TRENDS
    • 12.3.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
    • 12.3.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
    • 12.3.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
    • 12.3.4. INCREASE IN NON-INVASIVE DEVICES
    • 12.3.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
  • 12.4. REGULATION OF BLOOD SUGAR
  • 12.5. VALUE CHAIN ANALYSIS
  • 12.6. OPPORTUNITY MATRIX

13. REGIONAL ANALYSIS

  • 13.1. NORTH AMERICA
    • 13.1.1. THE UNITED STATES
      • 13.1.1.1. THE UNITED STATES HEALTH AND HEALTHCARE
      • 13.1.1.2. THE UNITED STATES PHARMACEUTICAL MARKET
    • 13.1.2. CANADA
      • 13.1.2.1. CANADA HEALTH AND HEALTHCARE
      • 13.1.2.2. CANADA PHARMACEUTICAL MARKET
      • 13.1.2.3. CANADA DIABETES MARKET

14. COMPETITIVE LANDSCAPE

  • 14.1. MARKET POSITION ANALYSIS
  • 14.2. COMPANY PROFILES
    • 14.2.1. ABBOTT
    • 14.2.2. APEX BIOTECHNOLOGY CORP.
    • 14.2.3. ARKRAY INC.
    • 14.2.4. ASCENSIA
    • 14.2.5. B BRAUN MELSUNGEN AG
    • 14.2.6. BECTON DICKINSON AND COMPANY
    • 14.2.7. DEXCOM
    • 14.2.8. GLYSENS INC.
    • 14.2.9. INSULET CORP.
    • 14.2.10. I-SENS INC.
    • 14.2.11. JOHNSON AND JOHNSON
    • 14.2.12. MEDTRONIC
    • 14.2.13. MOREPEN LABORATORIES LTD.
    • 14.2.14. NEMAURA MEDICAL INC.
    • 14.2.15. ROCHE DIAGNOSTICS
    • 14.2.16. SENSEONICS INC.
    • 14.2.17. TANDEM DIABETES CARE
    • 14.2.18. TERUMO
    • 14.2.19. WOCKHARDT
    • 14.2.20. YPSOMED

LIST OF TABLES

  • TABLE 1 NORTH AMERICA CGMS MARKET 2019-2027 ($ MILLION)
  • TABLE 2 NORTH AMERICA SMBG MARKET 2019-2027 ($ MILLION)
  • TABLE 3 DIABETES PREVALENCE IN NORTH AMERICA 2015-2040 (MILLIONS)
  • TABLE 4 NORTH AMERICA CGMS MARKET BY COMPONENT TYPE 2019-2027 ($ MILLION)
  • TABLE 5 NORTH AMERICA CGMS SENSORS MARKET 2019-2027 ($ MILLION)
  • TABLE 6 NORTH AMERICA CGMS TRANSMITTERS AND RECEIVERS MARKET 2019-2027 ($ MILLION)
  • TABLE 7 NORTH AMERICA CGMS INSULIN PUMP MARKET 2019-2027 ($ MILLION)
  • TABLE 8 NORTH AMERICA CGMS MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 9 NORTH AMERICA CGMS HOME SETTINGS MARKET 2019-2027 ($ MILLION)
  • TABLE 10 NORTH AMERICA CGMS DIAGNOSTICS AND CLINICAL MARKET 2019-2027 ($ MILLION)
  • TABLE 11 NORTH AMERICA CGMS HOSPITAL MARKET 2019-2027 ($ MILLION)
  • TABLE 12 NORTH AMERICA CGMS MARKET BY DEMOGRAPHICS 2019-2027 ($ MILLION)
  • TABLE 13 NORTH AMERICA CGMS ADULT POPULATION (>14YEARS) MARKET 2019-2027 ($ MILLION)
  • TABLE 14 NORTH AMERICA CGMS CHILD POPULATION (≤14YEARS) MARKET 2019-2027 ($ MILLION)
  • TABLE 15 IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS
  • TABLE 16 SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS
  • TABLE 17 PRODUCT MATRIX FOR LANCETS
  • TABLE 18 NORTH AMERICA SMBG MARKET BY COMPONENT TYPE 2019-2027 ($ MILLION)
  • TABLE 19 NORTH AMERICA SMBG LANCETS MARKET 2019-2027 ($ MILLION)
  • TABLE 20 NORTH AMERICA SMBG MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 21 NORTH AMERICA SMBG HOME SETTING MARKET 2019-2027 ($ MILLION)
  • TABLE 22 NORTH AMERICA SMBG CLINICAL MARKET 2019-2027 ($ MILLION)
  • TABLE 23 NORTH AMERICA SMBG HOSPITAL MARKET 2019-2027 ($ MILLION)
  • TABLE 24 NORTH AMERICA SMBG MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 25 NORTH AMERICA SMBG TYPE 1 DIABETES MARKET 2019-2027 ($ MILLION)
  • TABLE 26 NORTH AMERICA SMBG TYPE 2 DIABETES MARKET 2019-2027 ($ MILLION)
  • TABLE 27 NORTH AMERICA SMBG GESTATIONAL DIABETES MARKET 2019-2027 ($ MILLION)
  • TABLE 28 NORTH AMERICA SMBG MARKET 2019-2027 ($ MILLION)
  • TABLE 29 NORTH AMERICA CGMS MARKET 2019-2027 ($ MILLION)
  • TABLE 30 SMBG COMPANY MARKET POSITION ANALYSIS 2018
  • TABLE 31 CGMS COMPANY MARKET POSITION ANALYSIS 2018

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA CGMS MARKET SHARE BY COMPONENT TYPE 2018 & 2027 (%)
  • FIGURE 2 NORTH AMERICA CGMS MARKET BY SENSORS 2019-2027 ($ MILLION)
  • FIGURE 3 NORTH AMERICA CGMS MARKET BY TRANSMITTERS AND RECEIVERS 2019-2027 ($ MILLION)
  • FIGURE 4 NORTH AMERICA CGMS MARKET BY INSULIN PUMP 2019-2027 ($ MILLION)
  • FIGURE 5 NORTH AMERICA CGMS SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 6 NORTH AMERICA CGMS MARKET BY HOME SETTING 2019-2027 ($ MILLION)
  • FIGURE 7 NORTH AMERICA CGMS MARKET BY DIAGNOSTICS AND CLINICAL 2019-2027 ($ MILLION)
  • FIGURE 8 NORTH AMERICA CGMS MARKET BY HOSPITAL 2019-2027 ($ MILLION)
  • FIGURE 9 NORTH AMERICA CGMS MARKET SHARE BY DEMOGRAPHICS 2018 & 2027 (%)
  • FIGURE 10 NORTH AMERICA CGMS MARKET BY ADULT POPULATION (>14YEARS) 2019-2027 ($ MILLION)
  • FIGURE 11 NORTH AMERICA CGMS MARKET BY CHILD POPULATION (≤14YEARS) 2019-2027 ($ MILLION)
  • FIGURE 12 NORTH AMERICA SMBG MARKET SHARE BY COMPONENT TYPE 2018 & 2027 (%)
  • FIGURE 13 NORTH AMERICA SMBG MARKET BY TEST STRIPS 2019-2027 ($ MILLION)
  • FIGURE 14 NORTH AMERICA SMBG TEST STRIPS MARKET 2019-2027 ($ MILLION)
  • FIGURE 15 NORTH AMERICA SMBG MARKET BY GLUCOSE METER 2019-2027 ($ MILLION)
  • FIGURE 16 NORTH AMERICA SMBG GLUCOSE METER MARKET 2019-2027 ($ MILLION)
  • FIGURE 17 NORTH AMERICA SMBG LANCETS MARKET 2019-2027 ($ MILLION)
  • FIGURE 18 NORTH AMERICA SMBG MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 19 NORTH AMERICA SMBG MARKET BY HOME SETTING 2019-2027 ($ MILLION)
  • FIGURE 20 NORTH AMERICA SMBG MARKET BY CLINICAL 2019-2027 ($ MILLION)
  • FIGURE 21 NORTH AMERICA SMBG MARKET BY HOSPITAL 2019-2027 ($ MILLION)
  • FIGURE 22 NORTH AMERICA SMBG MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 23 NORTH AMERICA SMBG MARKET BY TYPE 1 DIABETES 2019-2027 ($ MILLION)
  • FIGURE 24 NORTH AMERICA SMBG MARKET BY TYPE 2 DIABETES 2019-2027 ($ MILLION)
  • FIGURE 25 NORTH AMERICA SMBG MARKET BY GESTATIONAL DIABETES 2019-2027 ($ MILLION)
  • FIGURE 26 PORTER'S FIVE FORCE MODEL
  • FIGURE 27 VALUE CHAIN OF CGMS MARKET
  • FIGURE 28 THE UNITED STATES CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 THE UNITED STATES SMBG MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 CANADA CGMS MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 CANADA SMBG MARKET 2019-2027 ($ MILLION)
Back to Top